Young people in England aged 12-15 to be offered COVID-19 vaccine
The Health and Social Care Secretary has announced that people aged 12 to 15 in England will be offered one dose of the Pfizer/BioNTech...
UK Government terminates COVID-19 vaccine agreement with Valneva
The French speciality vaccine company, Valneva, has announced that it has received a termination notice from the UK Government in relation to the Supply...
JCVI issues advice on third dose COVID-19 vaccination for severely immunosuppressed
The Joint Committee on Vaccination and Immunisation (JCVI) is advising that people with severely weakened immune systems should have a third vaccine dose as...
CMA warns PCR COVID-19 test providers against breaching consumer law
The CMA has sent an open letter to PCR COVID-19 test providers warning that a range of harmful practices in the sector could breach...
JCVI advises all UK 16- and 17-year-olds should be offered COVID-19 vaccine
The Joint Committee on Vaccination and Immunisation (JCVI) has issued advice that all 16 to 17-year-olds should be offered a first dose of the...
Study shows AZ’s COVID-19 vaccine did not increase rate of rare blood clots after...
Data published in The Lancet has demonstrated that AstraZeneca’s COVID-19 jab Vaxzevria (formerly AZD1222) does not increase the rate of rare blood clots after...
NHS Providers letter states NHS pressures match height of the pandemic
NHS Providers says the health service has, over the last month, become as stretched as it was at the height of the pandemic in...
JCVI advises vaccination for children at increased risk of serious COVID-19
The Joint Committee on Vaccination and Immunisation (JCVI) is advising that children at increased risk of serious COVID-19 disease are offered the Pfizer-BioNTech vaccine. That includes children...
COVID: A new wave of interest in pharma, what learnings can we take into...
My Mum, Mary, aged 73, is a retired hairdresser, and this past year she’s discovered a new passion. Medical science. COVID-19 hasn’t left the...
PHE study shows COVID-19 vaccines highly effective in most people in at-risk groups
A study from Public Health England (PHE), including more than 1 million people in at-risk groups, has demonstrated that COVID-19 vaccines are as effective...
Latest articles
Enter today! The Pf Awards 2022 are officially open
New Year | New Suite of Categories | New Candidates
Would you like to be recognised as a top performer in the UK Pharmaceutical industry? Enter...
New study to explore if talazoparib could treat metastatic breast cancer
A new study funded by Breast Cancer Now will explore if the drug talazoparib (Talzenna) could be used to treat people with incurable secondary...
£250m winter access fund for GPs to boost face to face appointments
The NHS has published a blueprint for improving access to GP appointments for patients alongside supporting GPs and their teams. Surgeries will be provided with additional funding...
Popular articles
New Normal, New Thinking: Life Post COVID-19
New thinking will be required to adapt to the new normal life post COVID-19. I hate to start this article on a negative note, but...
Pancreatic Cancer Story: James Dadge
James, 44, lives in Manchester with his partner Andrea and sons Ben and Daniel. He was diagnosed with a neuroendocrine tumour, with the primary...
Pancreatic Cancer Story: John William Street
Pancreatic cancer is the 10th most common cancer in the UK, with around 10,000 people diagnosed each year. The disease has the lowest survival...
A CLASS DIVIDED – A LIFE CHANGING EXPERIMENT
What can your team learn about positive thinking from a schoolteacher in the 1970s and a world heavy weight champion? Ama Verdi-Ashton explains. It...
Pharma marketing: UK vs US
Marketing medicines is a totally different ball game on each side of the pond.
The US is the only country, apart from New Zealand, which...